Broxyquinoline
![]() | |
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | A07AX01 (WHO) G01AC06 (WHO) P01AA01 (WHO) |
Identifiers | |
| |
CAS Number |
521-74-4 ![]() |
PubChem (CID) | 2453 |
ChemSpider |
2359 ![]() |
UNII |
UK4C618C8T ![]() |
ChEMBL |
CHEMBL223448 ![]() |
ECHA InfoCard | 100.007.563 |
Chemical and physical data | |
Formula | C9H5Br2NO |
Molar mass | 302.95 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
![]() ![]() |
Broxyquinoline is an antiprotozoal agent.
An association with exercise intolerance has been reported.[1]
References
- ↑ Swain R, Bapna JS (January 1986). "Impairment of exercise tolerance due to broxyquinoline-brobenzoxaldine combination". Hum Toxicol. 5 (1): 63–4. doi:10.1177/096032718600500115. PMID 3081430.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.